Abstract
We characterized the performance of the NeuroPET/CT and showed images from the first human studies. The study shows that this scanner achieves good performance when spatial resolution, sensitivity, counting rate, and image quality along with a low cost and unique mobile capabilities are considered.
Introduction
Positron Emission Tomography (PET) is a cornerstone of modern neuroimaging, vital for diagnosing neurodegenerative conditions like Alzheimer’s disease and monitoring brain tumors. However, conventional PET scanners are typically large, stationary, and expensive installations. This requires patients—who may be critically ill or cognitively impaired—to be transported to a dedicated imaging suite. Furthermore, full-body scanners are not optimized for the brain; their large bore sizes often result in compromised sensitivity and spatial resolution for head-only imaging.
The NeuroPET/CT addresses these challenges as a first-of-its-kind mobile, dedicated brain PET/CT scanner. By leveraging high-sensitivity silicon photomultipliers (SiPMs) and a unique battery-powered propulsion system, it brings high-end molecular imaging directly to the patient’s bedside without sacrificing diagnostic quality.
System Design and Mobility
The NeuroPET/CT is engineered for portability and performance. Its detector ring is significantly smaller (35.7 cm diameter) than standard full-body scanners (~82 cm), placing detectors closer to the brain to maximize photon capture.
Key Hardware Features: * Detector Modules: The system utilizes seven modules of cerium-doped lutetium yttrium orthosilicate (LYSO:Ce) crystals arranged in two layers. This dual-layer design is intended to eventually support depth-of-interaction (DOI) measurements to mitigate parallax blurring. * SiPM Sensors: Replacing traditional bulky photomultiplier tubes with 12 × 12 arrays of Silicon Photomultipliers (SiPMs) allowed for a more compact and robust detector assembly. * Propulsion System: The scanner is battery-powered and self-propelled. It uses wheels for rapid transport through hospital corridors and switches to high-precision treads for controlled movement during CT acquisition.
Performance Evaluation (NEMA Standards)
The researchers benchmarked the NeuroPET/CT using the NEMA NU2-2012 standards, comparing it against the Siemens ECAT Exact HR+ full-body scanner.
Spatial Resolution and Sensitivity
The NeuroPET/CT demonstrated superior spatial resolution, achieving 3.2 mm (transverse, at 1 cm radius) compared to the 4.5 mm of the reference HR+ scanner. This improvement is largely due to the smaller detector ring and optimized crystal geometry.
In terms of sensitivity—the system's efficiency in detecting coincidence events—the NeuroPET/CT reached a peak of 11.7 kcps/MBq. This is nearly double the sensitivity of many older-generation full-body systems, potentially allowing for lower tracer doses or significantly reduced scan times.
Clinical Validation and Image Quality
The system was validated through a series of phantom studies and human clinical trials involving over 50 subjects. A subset of 33 patients underwent scans on both the NeuroPET/CT and the reference HR+ scanner to evaluate the consistency of Standardized Uptake Values (SUVs).
The clinical results showed an excellent correlation (regression slope of 1.04) between the two systems. Visual analysis of the $^{18}$F-FDG brain scans revealed that the NeuroPET/CT provided more distinct gray-matter features, confirming that its technical gains in resolution translate into improved clinical image quality.
Discussion and Future Directions
While the NeuroPET/CT represents a significant leap in mobile imaging, there are areas for further optimization. The current reconstruction software does not yet fully utilize the dual-layer crystal information for Depth of Interaction (DOI) correction. Implementing DOI will further sharpen resolution at the edges of the field of view. Additionally, while the PET component is highly mobile, the integrated CT requires standard radiation safety protocols (maintaining a 1.5m to 3m distance) during bedside operation.
In conclusion, the NeuroPET/CT proves that "mobile" and "low-cost" do not necessitate a compromise in performance. Its combination of high sensitivity, superior resolution, and unique mobility makes it a powerful tool for expanding the reach of advanced neuroimaging in diverse clinical environments.
Summary updated